ADMA INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that ADMA Biologics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit
· robbins geller rudman & dowd llp
Source Summary
The case alleges ADMA Biologics and certain of its executives made false and/or misleading statements to investors.
Advertisement